1. Semi-quantitative scoring of skeletal metastases by ¹²³I-mIBG scintigraphy in high-risk neuroblastoma

   • Mark N. Gaze

   Editorial 03 March 2017 Pages: 1251 - 1253

2. Advanced Hodgkin’s lymphoma: End-of-treatment FDG-PET should be maintained

   • Elif Hindié
   • Charles Mesguich
   • Noël Milpied

   Editorial 02 May 2017 Pages: 1254 - 1257

3. Diagnostic performance of ⁶⁸Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients

   • Ali Afshar-Oromieh
   • Tim Holland-Letz
   • Uwe Haberkorn

   Original Article Open access 12 May 2017 Pages: 1258 - 1268

   

4. Comparison of CT and PET/CT for biopsy guidance in oncological patients

   • Juliano J. Cerci
   • Elena Tabacchi
   • João Vicente Vitola

   Original Article 31 March 2017 Pages: 1269 - 1274

   

5. Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer

   • Joshua H. Finkle
   • Stephanie Y. Jo
   • Yonglin Pu

   Original Article 07 March 2017 Pages: 1275 - 1284

   

6. Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study

   • Cornelius Deuschl
   • Christoph Moenninghoff
   • Marc Schlamann

   Original Article 03 March 2017 Pages: 1285 - 1295

   

7. Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer

   • Dawei Jiang
   • Hyung-Jun Im
   • Weibo Cai

   Original Article 06 March 2017 Pages: 1296 - 1305

   

8. IDH mutation is paradoxically associated with higher ¹⁸F-FDOPA PET uptake in diffuse grade II and grade III gliomas

   • A. Verger
   • Ph. Metellus
   • E. Guedj

   Original Article 14 March 2017 Pages: 1306 - 1311

   

9. Impact of ¹⁸F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysis

   • Andrea Forschner
   • Susann-Cathrin Olthof
   • Christina Pfannenberg

   Original Article 18 March 2017 Pages: 1312 - 1318

   

10. A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial

    • Joyce M. van Dodewaard-de Jong
    • John M. H. de Klerk
    • Alfons J. M. van den Eertwegh

    Original Article 18 April 2017 Pages: 1319 - 1327

    

11. ⁸⁹Zr-Onartuzumab PET imaging of c-MET receptor dynamics

    • Martin Pool
    • Anton G. T. Terwisscha van Scheltinga
    • Marjolijn N. Lub-de Hooge

    Original Article Open access 19 March 2017 Pages: 1328 - 1336

    

12. Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT

    • Dan Sandberg
    • Vladimir Tolmachev
    • Jens Sörensen

    Original Article Open access 06 March 2017 Pages: 1337 - 1346

    

13. Preclinical imaging characteristics and quantification of Platinum-195m SPECT

    • E. A. Aalbersberg
    • B. J. de Wit – van der Veen
    • Wouter V. Vogel

    Original Article 11 February 2017 Pages: 1347 - 1354

    

14. Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline

    • Nare Torosyan
    • Kelsey Mason
    • the Alzheimer’sDisease Neuroimaging Initiative

    Original Article 22 March 2017 Pages: 1355 - 1363

    

15. Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden

    • Janusch Blautzik
    • Matthias Brendel
    • for the Alzheimer’s Disease Neuroimaging Initiative

    Original Article 22 March 2017 Pages: 1364 - 1374

    

16. The relationship between the dopaminergic system and depressive symptoms in cervical dystonia

    • E. Zoons
    • M. A. J. Tijssen
    • J. Booij

    Original Article Open access 17 March 2017 Pages: 1375 - 1382

    

17. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis

    • Lien Bekaert
    • Samuel Valable
    • Jean-Sébastien Guillamo

    Original Article 18 March 2017 Pages: 1383 - 1392

    

18. Accuracy of diagnostic imaging modalities for peripheral post-traumatic osteomyelitis – a systematic review of the recent literature

    • Geertje A. Govaert
    • Frank F. IJpma
    • Andor W. Glaudemans

    Review Article Open access 27 April 2017 Pages: 1393 - 1407

    

19. Is the information provided by amino acid PET radiopharmaceuticals clinically equivalent in gliomas?

    • A. Verger
    • D. Taieb
    • E. Guedj

    Letter to the Editor 27 April 2017 Pages: 1408 - 1410

20. “The simplest explanation is usually the correct one” – Can Occam’s razor be applied for diffuse astrocytoma and paradoxical amino acid metabolism?

    • Egesta Lopci

    Reply 03 May 2017 Pages: 1411 - 1412

21. Hypercalcemia revealing diffuse granulomatous myositis

    • Weniko Caré
    • Estelle Blanc
    • Stéphane Lecoules

    Image of the Month 10 April 2017 Pages: 1413 - 1414

    

22. Valentina Ambrosini and Stefano Fanti (eds): Clinicians’ Guides to Radionuclide Hybrid Imaging: PET/CT in Neuroendocrine Tumors

    • Manuela Amato
    • Luigi Mansi

    Book Review 26 January 2017 Pages: 1415 - 1415